[Use of levosimendan after cardiac arrest by ventricular fibrillation: a case report].
We describe the case of a patient admitted in intensive care, after cardiac arrest by ventricular fibrillation treated by electrical defibrillation, that showed a serious deficit of the cardiac index and increase of the systemic vascular resistances. The patient was treated by levosimendan (Simdax): a starter dose of 12 microg/Kg in ten minutes and then a continuous perfusion of 0.1 microg/Kg/min. for 24 hours. He had a continuous amelioration of the clinical conditions and of the hemodynamics parameters. In the fifth day the patient was transferred to the Cardiology department and after 20 days he was discharged from hospital.
Verre
M
M
Unità Operativa di Anestesia, Rianimazione, Terapia Intensiva, Ospedale "S. Giovanni di Dio" ASL n.5, Crotone. marioverre@tiscali.it
Bossio
F
F
Durante
M
M
Muraca
G
G
Tancioni
F
F
Tiburzi
S
S
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D003422:Critical Care; D004554:Electric Countershock; D004562:Electrocardiography; D006323:Heart Arrest / Q000209:etiology* / Q000628:therapy; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000150:complications / Q000188:drug therapy* / Q000628:therapy
D000889:Anti-Arrhythmia Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan